Biomarker Guided Therapy for Heart Failure: Focus on Natriuretic Peptides

ISSN: 1875-6557 (Online)
ISSN: 1573-403X (Print)


Volume 10, 4 Issues, 2014


Download PDF Flyer




Current Cardiology Reviews

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Fei Lu
University of Minnesota Medical School
Minneapolis, MN 55455
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Biomarker Guided Therapy for Heart Failure: Focus on Natriuretic Peptides

Author(s): Amanda E. Pruett, Amanda K. Lee, J. Herbert Patterson, Todd A. Schwartz, Jana M. Glotzer and Kirkwood F. Adams

Affiliation: University of North Carolina Chapel Hill, 6034 Burnett-Womack Bldg, CB# 7075 160 Dental Circle, Chapel Hill, NC 27599

Abstract

Optimizing management of patients with heart failure remains quite challenging despite many significant advances in drug and device therapy for this syndrome. Although a large body of evidence from robustclinical trials supportsmultiple therapies, utilization of these well-established treatmentsremains inconsistent and outcomes suboptimal in “real-world” patients with heart failure. Disease management programs may be effective, but are difficult to implement due to cost and logistical issues. Another approach to optimizing therapy is to utilize biomarkers to guide therapeutic choices. Natriuretic peptides provide additional information of significant clinical valuein the diagnosis and estimation of risk inpatients with heart failure. Ongoing research suggests a potential important added rolefor natriuretic peptides in heart failure. Guiding therapy based on serial changes in these biomarkers may be an effective strategy to optimize treatment and achieve better outcomes in this syndrome. Initial, innovative, proof-of-concept studies have provided encouraging results and important insights into key aspects of this strategy, but well designed, large-scale, multicenter, randomized, outcome trials are needed to definitively establish this novel approach to management. Given the immense and growing public health burden of heart failure, identification of cost-effective ways to decrease the morbidity and mortality due to this syndrome is critical

Keywords: Biomarker, guided, heart failure, natriuretic peptides

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 9
First Page: 1
Last Page: 10
Page Count: 10
DOI: 10.2174/1573403X09666131117123525
Advertisement

Related Journals



Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science